| |
| |
|
| Insider
Information: |
Marshall Keith W |
| Relationship: |
Chief Financial Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
19,885 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,980 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
19,885 |
|
|
| Total
Value |
$6,980 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Histogen Inc |
HSTO |
EVP, COO & CFO |
2020-05-22 |
19,885 |
|
0 |
Premium* |
|
|
Prometheus Biosciences, Inc. |
RXDX |
Chief Financial Officer |
2023-06-16 |
0 |
2022-12-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RXDX |
Prometheus Biosciences, I... |
Chief Financial Officer |
• – – |
2023-06-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(87,973) |
0 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Chief Financial Officer |
• – – |
2023-06-02 |
4 |
OE |
$3.10 |
$242,302 |
D/D |
78,162 |
87,973 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Chief Financial Officer |
• – – |
2023-04-05 |
4 |
AS |
$108.42 |
$1,084,200 |
D/D |
(10,000) |
9,811 |
0 |
% |
|
| RXDX |
Prometheus Biosciences, I... |
Chief Financial Officer |
• – – |
2023-04-05 |
4 |
OE |
$3.70 |
$37,000 |
D/D |
10,000 |
19,811 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Chief Financial Officer |
• – – |
2023-03-06 |
4 |
AS |
$122.13 |
$1,221,300 |
D/D |
(10,000) |
9,811 |
0 |
% |
|
| RXDX |
Prometheus Biosciences, I... |
Chief Financial Officer |
• – – |
2023-03-06 |
4 |
OE |
$3.70 |
$37,000 |
D/D |
10,000 |
19,811 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Chief Financial Officer |
• – – |
2023-02-15 |
4 |
AS |
$119.38 |
$596,900 |
D/D |
(5,000) |
9,811 |
0 |
% |
|
| RXDX |
Prometheus Biosciences, I... |
Chief Financial Officer |
• – – |
2023-02-15 |
4 |
OE |
$3.70 |
$18,500 |
D/D |
5,000 |
14,811 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Chief Financial Officer |
• – – |
2023-01-17 |
4 |
AS |
$119.00 |
$595,000 |
D/D |
(5,000) |
9,811 |
0 |
% |
|
| RXDX |
Prometheus Biosciences, I... |
Chief Financial Officer |
• – – |
2023-01-17 |
4 |
OE |
$3.70 |
$18,500 |
D/D |
5,000 |
14,811 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Chief Financial Officer |
• – – |
2022-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
9,811 |
9,811 |
0 |
- |
|
| HSTO |
Histogen Inc |
EVP, COO & CFO |
• – – |
2020-05-22 |
4 |
D |
$0.56 |
$10,424 |
D/D |
(18,615) |
19,885 |
0 |
- |
|
| HSTO |
Histogen Inc |
EVP, COO & CFO |
• – – |
2020-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
38,500 |
38,500 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
